Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women

Author： Lai B.   Cheung C.   Luk K.   Kung A.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.19, Iss.4, 2008-04, pp. : 571-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women

By Bainbridge Kathleen   Sowers MaryFran   Lin Xihong   Harlow Sioban  

Osteoporosis International, Vol. 15, Iss. 6, 2004-06 ,pp. : 439-446

Springer Publishing Company

Access to resources Recommend Favorite

The Sp1 COLIA1 Gene Polymorphism, and Not Vitamin D Receptor or Estrogen Receptor Gene Polymorphisms, Determines Bone Mineral Density in Postmenopausal Greek Women

By Efstathiadou Z.   Kranas V.   Ioannidis J. P. A.   Georgiou I.   Tsatsoulis A.  

Osteoporosis International, Vol. 12, Iss. 4, 2001-05 ,pp. : 326-331

Springer Publishing Company

Access to resources Recommend Favorite

No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.

By Rejnmark L.   Vestergaard P.   Charles P.   Hermann A.   Brot C.   Eiken P.   Mosekilde L.  

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 872-880

Springer Publishing Company

Access to resources Recommend Favorite

Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women

By Erdogan M.   Yıldız H.   Artan S.   Solak M.   Taşcıoğlu F.   Dündar Ü.   Eser B.   Çolak E.  

Osteoporosis International, Vol. 22, Iss. 4, 2011-04 ,pp. : 1219-1225

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate

By Watts N. B.   Jenkins D. K.   Visor J. M.   Casal D. C.   Geusens P.  

Osteoporosis International, Vol. 12, Iss. 4, 2001-05 ,pp. : 279-288

Springer Publishing Company

Access to resources Recommend Favorite